AUDRA DEARDORF: Open Payments
NPI 1467946111 · GARRETT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 89 payments from 18 companies in 2025. Trend: 2023 $79 · 2024 $404 · 2025 $1,565
Food & beverage: $1,565
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $390 |
| ABBVIE INC. | 24 | $293 |
| Lilly USA, LLC | 8 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $142 |
| Novo Nordisk Inc | 7 | $112 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
Products named: BREZTRI, VRAYLAR, CAPLYTA, FARXIGA, Wegovy, Auvelity, MOUNJARO, ZEPBOUND.
Industry payments across IN — which companies pay providers there.
